My Quality Solutions

5B9 Monoclonal Antibody: Fully mimics the effects of human HIT antibodies

5B9 is a monoclonal antibody that fully mimics the effects of human Heparin Induced Thrombocytopenia (HIT) antibodies [1]:

anti-PF4/Heparin IgG antibody with human Fc fragment,
induces heparin- and FcϒRIIA-dependent platelet activation,
specific to the PF4/Heparin complex with very low reactivity against PF4 alone.

5B9 clinical research on HIT functional assays covers the following objectives:

My Personal Space: Your new customer area, now available!

For over 10 years, you have had access to your own special Customer area. As part of our desire to bring you more digital services, Stago is now launching My Personal Space, a new customer portal tailored to your new needs.

5B9 Monoclonal Antibody kits are available in stock to order

5B9 Monoclonal Antibody: Fully mimics the effects of human HIT antibodies [1]

5B9 is a monoclonal antibody that fully mimics the effects of human Heparin Induced Thrombocytopenia (HIT) antibodies:

Stago introduces a new flow analysis service: MyOptiLab

The new MyOptiLab workflow analysis service is part of a broader strategy aimed at working more closely with laboratories. It is an elaborate process designed to optimise organisational excellence.

Stago is proud to offer an innovative bleeding management solution, the Quantra®

This innovative in vitro diagnostic platform is designed to assess a patient’s coagulation status by measuring changes in viscoelastic properties of a blood sample during clot formation in surgical and intensive care setting.